CIDARA THERAPEUTICS INC (CDTX) Top Institutional Shareholders
CIDARA THERAPEUTICS INC (CDTX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended December 31, 2025. The institutional investors covered on this page collectively reported approximately $70.87M in CDTX holdings during the latest filing period.
Oconnor, A Distinct Business Unit Of Ubs Asset Management Americas (Llc) is currently the largest disclosed institutional shareholder of CDTX tracked by InsiderSet, reporting ownership valued at approximately $69.69M in its December 31, 2025 SEC Form 13F filing.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed CDTX value among the investors covered in this analysis. Major shareholders include Oconnor, A Distinct Business Unit Of Ubs Asset Management Americas (Llc), Transmarket Holdings Lp, and several other long-term asset managers with concentrated positions in CIDARA THERAPEUTICS INC (CDTX).
This page ranks the largest institutional CDTX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
2
Total Reported Value
$70.87M
Largest Holder
Oconnor, A Distinct Business Unit Of Ubs Asset Management Americas (Llc)
Largest Position
$69.69M
Insider Transactions (90d)
0
Latest Filing Quarter
Q4 2025
New Institutional Positions
238
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Oconnor, A Distinct Business Unit Of Ubs Asset Management Americas (Llc) | 8.22% | 315,474 | $69,685,052 | — | — | — | |
| Transmarket Holdings Lp | 0.37% | 5,360 | $1,183,970 | — | — | — |
Frequently asked questions about CDTX
Who owns the most CDTX stock?
The largest holders of CDTX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for CIDARA THERAPEUTICS INC (CDTX).
Is CDTX widely held by superinvestors?
Many widely followed stocks like CDTX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly CDTX is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.